header for pages

  



USA / Grants   previous grant / next grant   



Contact: Erwin Böttinger, M.D. , Director of the Charles Bronfman
  Institute for Personalized Medicine
phone: 212-241-0800
email: erwin.bottinger@mssm.edu


  Newsletter:  Gift Will Create New Institute for Personalized Medicine, Inside Mount Sinai, April 16-22, 2007
  Article: Profiles in Family Philanthropy Family Giving News, May /June 2007
  Podcast:Interview with Erwin Bottinger, M.D., Winter 2007


The Charles R. Bronfman Institute of Personalized Medicine


Charles Bronfman Institute for Personalized Medicine at The Mount Sinai Medical Center will help propel Mount Sinai to the forefront of personalized medicine, an emerging field that uses information about a person’s genetic make-up to customize strategies for the detection, treatment, and prevention of disease. The $12.5 million ACBP gift will be used to fund an institution-wide Biobank at Mount Sinai and to establish the Translational Biomedical Informatics Center, two areas of focus for the Institute for Personalized Medicine, seed-funding Mount Sinai's overall $30 million personalized medicine initiative. The grant will be paid out over a period of 10 years.

Personalized medicine transforms the traditional "one-size-fits-all" model of medicine by utilizing new methods of molecular analysis to better manage a patient’s disease or predisposition toward a disease. It represents a dramatic departure from "evidence-based medicine," which is based on population studies and has dominated medical principles for decades. While the evidence-based approach does allow doctors to modify treatment strategies according to a particular patient's response, it relies on trial-and-error and lacks precision. Personalized medicine, on the other hand, gives doctors an answer based on an individual’s unique set of genes and thereby reduces uncertainty and error in diagnosis and treatment.



footer  




about  |  press  |  canada  |  israel  |  united states  |  contact